Lim Beng Liam, Vote Brendan
The Eye Hospital, Launceston, Tasmania, Australia.
Clin Exp Ophthalmol. 2008 Apr;36(3):261-4. doi: 10.1111/j.1442-9071.2008.01721.x.
To report on the use of Densiron (heavy silicone oil), a new endotamponade agent with proposed benefits in complex retinal detachments involving inferior proliferative vitreoretinopathy.
Retrospective case note review.
Ten cases (10 eyes) in which Densiron was used in eyes which had failed initial retinal detachment surgery. The overall success rate of long-term total reattachment was 70%. Mean preoperative visual acuity was logMAR 2.03 (SD 0.406), which improved to a mean postoperative visual acuity of logMAR 1.00 (SD 0.571) (P = 0.001).
Densiron was well tolerated with few side-effects and appears to be a useful agent in patients with inferior proliferative vitreoretinopathy.
报告新型眼内填充剂Densiron（重硅油）在伴有下方增殖性玻璃体视网膜病变的复杂性视网膜脱离中的应用情况，该填充剂具有潜在益处。
回顾性病例记录分析。
10例（10只眼）曾行视网膜脱离初次手术失败后使用Densiron的病例。长期完全复位的总体成功率为70%。术前平均视力为logMAR 2.03（标准差0.406），术后平均视力提高至logMAR 1.00（标准差0.571）（P = 0.001）。
Densiron耐受性良好，副作用少，似乎是治疗下方增殖性玻璃体视网膜病变患者的有效药物。
